Investment
Features
FeesSafety
Academy
More
Pluang+

DADDY token drops 24% after Tate brothers arrested and charged in UK

Market News
19 Jul 2026
BeInCrypto
View Source
Bearish
pluang ai news

The DADDY token, linked to Andrew Tate's brand, fell 24% following the arrest of Andrew and Tristan Tate in Miami on a UK extradition request. UK prosecutors added 38 new charges, bringing Andrew Tate's total to 42 and Tristan's to 17, including serious allegations like rape and trafficking. The token's price dropped to about $0.011, down 96% from its 2024 peak, reflecting thin trading volume and market sensitivity to the brothers' legal issues. The next key event is the extradition hearings, which will likely influence the token's future movements.

More News

USA Rare Earth names Thras Moraitis as new CEO, Barbara Humpton to retire Oct 1, 2026

USA Rare Earth names Thras Moraitis as new CEO, Barbara Humpton to retire Oct 1, 2026

USA Rare Earth announced that CEO Barbara Humpton will retire on October 1, 2026, with Thras Moraitis, current CEO of Serra Verde Group, succeeding her. Moraitis will become CEO following the completion of the merger between USA Rare Earth and Serra ...

Company Fundamentals
Bullish
39 minutes ago
Positive Phase 2a data for Namodenoson in advanced pancreatic cancer accepted for presentation at ESMO 2026.

Positive Phase 2a data for Namodenoson in advanced pancreatic cancer accepted for presentation at ESMO 2026.

Can-Fite BioPharma announced that positive Phase 2a study results of Namodenoson, a drug for advanced pancreatic ductal adenocarcinoma, have been accepted for presentation at the ESMO Congress 2026. The study showed durable disease stabilization and ...

Market News
Bullish
39 minutes ago
Alternative Ballistics launches The Home Defense™ in Indonesia via PT Panglima Pandawa Sakti, expanding global sales.

Alternative Ballistics launches The Home Defense™ in Indonesia via PT Panglima Pandawa Sakti, expanding global sales.

Alternative Ballistics Corporation has partnered with Indonesian company PT Panglima Pandawa Sakti to introduce The Home Defense™, a less-lethal self-defense system, to qualified customers in Indonesia. This marks the company's first international di...

Market News
Bullish
39 minutes ago
OKYO Pharma files annual report, boosts cash to $20.6M, and advances Phase 3 trial for neuropathic corneal pain drug.

OKYO Pharma files annual report, boosts cash to $20.6M, and advances Phase 3 trial for neuropathic corneal pain drug.

OKYO Pharma filed its annual report for fiscal year ending March 31, 2026, highlighting a strengthened cash position of $20.6 million after raising about $25 million in the year. This financial boost supports the upcoming global Phase 3 NEPTUNE trial...

Company Fundamentals
Bullish
39 minutes ago
Harrow presents new clinical data supporting IHEEZO and BYOOVIZ at ASRS 2026, boosting confidence in retina treatments.

Harrow presents new clinical data supporting IHEEZO and BYOOVIZ at ASRS 2026, boosting confidence in retina treatments.

Harrow, Inc. announced three new studies at the ASRS 2026 meeting supporting its retina products IHEEZO, a low-viscosity ocular anesthetic gel, and BYOOVIZ, an FDA-approved biosimilar to LUCENTIS. Early trial data suggest IHEEZO improves patient comf...

Market News
Bullish
39 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App